Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/australias-asic-wants-to-expand-relief-measures-for-afsl-holders/